Kerecis has released Shield Spiral, an extension of its Kerecis Shield silicone fish-skin combination product range.
The fish-skin graft and silicone combination has perforated fenestration marks cut in a spiral pattern, which the company said allows easy customization. The 30 mm graft can be reduced to as little as 15 mm by peeling away the 2 mm outer spiral sections and cutting to the desired size.
Shield Spiral’s porous, silicone contact later provides for optimal integration and healing.
The Kerecis Shield product family also consists of Shield Adhesive and Shield Standard. These products manage chronic and acute wounds like diabetic foot ulcers, pressure ulcers, vascular ulcers, post-Moh's surgical wounds, and draining wounds.
The grafts contain natural skin elements and are fenestrated for adequate wound drainage for wound moisture at the wound bed. When grafted onto damaged human tissue or implanted, the material supports the body’s process to heal and degenerate.
No risk of disease transfer exists between cold-water fish and humans, so the Kerecis fish skin is gently processed to retain similarity to human tissue. The processing preserves the skin’s 3D structure, maintains natural strength, complexity, and molecules like fatty acids.
Kerecis is currently the only approved manufacturer of medical devices containing intact fish skin. The company was acquired by Coloplast in a $1.3 billion deal last year.
"At Kerecis, we continue to be inspired by the insights of the doctors that use the intact fish-skin every day," said Kerecis founder and CEO Fertram Sigurjonsson. “The development of Shield Spiral is a direct result of feedback from doctors that asked for a product that could be shaped faster and easier to the size of smaller wounds.”